Detalhe da pesquisa
1.
Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer.
BMC Cancer
; 23(1): 605, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391708
2.
Parallel Proteomic Workflow for Mass Spectrometric Analysis of Tissue Samples Preserved by Different Methods.
Anal Chem
; 90(9): 5841-5849, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624047
3.
Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
J Urol
; 197(3 Pt 1): 590-595, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746284
4.
Emmprin Expression Predicts Response and Survival following Cisplatin Containing Chemotherapy for Bladder Cancer: A Validation Study.
J Urol
; 194(6): 1575-81, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119672
5.
Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
Am J Pathol
; 182(2): 339-49, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23201130
6.
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
BMC Urol
; 14: 36, 2014 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885195
7.
Correction: Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
PLoS One
; 19(5): e0304890, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38820327
8.
Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
Am J Pathol
; 180(5): 1824-34, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22449953
9.
Tumour expression of bladder cancer-associated urinary proteins.
BJU Int
; 112(3): 407-15, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23470167
10.
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
BMC Urol
; 13: 17, 2013 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23565664
11.
An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers.
EBioMedicine
; 88: 104452, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724681
12.
Proteomic analysis of urinary biomarker candidates for nonmuscle invasive bladder cancer.
Proteomics
; 12(1): 135-44, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22065568
13.
PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity.
Sci Rep
; 12(1): 12186, 2022 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35842542
14.
An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
Can J Urol
; 18(4): 5778-86, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21854709
15.
Combination of biomarkers for neoadjuvant systemic chemotherapy before cystectomy in patients with urinary bladder cancer.
Transl Res
; 235: 77-84, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33766713
16.
Proteomic comparison between different tissue preservation methods for identification of promising biomarkers of urothelial bladder cancer.
Sci Rep
; 11(1): 7595, 2021 04 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33828141
17.
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations.
PLoS One
; 16(7): e0253178, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34232958
18.
The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types.
EBioMedicine
; 65: 103269, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33706249
19.
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer.
Nat Commun
; 12(1): 2301, 2021 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33863885
20.
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma.
Int J Cancer
; 126(6): 1390-402, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19821490